Our current development work focuses on building an exhaustive neuro suite offering a complete package of neuroradiology solutions. This includes a range of relevant biomarkers for neurovascular and neuro-oncological conditions.
Next to the current functionalities of Quantib™ ND, which offer accurate segmentation of various brain tissues, we are working on longitudinal analysis, white matter hyper-intensity detection and segmentation of lobes and hippocampus. Also normative reference curves for brain volumes will be included in the future.
Release of the next Quantib™ ND version is expected in Q2 2018.